Skip to content

Efficacy analysis of endoscopic placement of self-expanding metal stents with or without nasobiliary drainage in patients with malignant biliary obstruction

Efficacy analysis of endoscopic placement of self-expanding metal stents with or without nasobiliary drainage in patients with malignant biliary obstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095327
Enrollment
Unknown
Registered
2025-01-06
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant biliary obstruction

Interventions

Observation group:None

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a. Patients diagnosed with primary or secondary liver, bile duct, gallbladder, pancreas or periampullary malignant tumors by pathology or imaging examination, but cannot be treated by surgical resection due to tumor metastasis or poor systemic status b. The patient has obvious biliary obstruction manifestations (jaundice, abdominal distention, loss of appetite, etc.) c. Age > = 18 years d. First time to receive ERCP and placement of biliary uncovered metal stent, with or without ERBD.

Exclusion criteria

Exclusion criteria: a. Previous history of cholecystectomy b. Patients with gallbladder stones and bile duct stones c. Patients undergoing pancreatic duct stenting during surgery d. Patients who have already had PTCD e.Patients with preoperative diagnosis of acute cholangitis

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative cholangitis;

Secondary

MeasureTime frame
Incidence of postoperative acute pancreatitis;Perforation;Hemorrhage/bleeding;Death;Improvement rate of laboratory test indicators;Success rate of biliary drainage;Hospital stays;

Countries

China

Contacts

Public ContactKai Liu

The First Hospital of Jilin University

jinhw2022@163.com+86 178 0805 7258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026